key: cord-0896691-l76tldts authors: Narang, Jatin; Nowacki, Amy S.; Seballos, Spencer S.; Wang, Philip R.; Mace, Sharon E. title: D-dimer can help differentiate suspected pulmonary embolism patients that require anti-coagulation date: 2020-08-31 journal: Am J Emerg Med DOI: 10.1016/j.ajem.2020.08.086 sha: f35ad19265ed36f49704d044c0461734c8a81d97 doc_id: 896691 cord_uid: l76tldts OBJECTIVES: Determine whether D-dimer concentration in the absence of imaging can differentiate patients that require anti-coagulation from patients who do not require anti-coagulation. METHODS: Data was obtained retrospectively from 366 hemodynamically stable adult ED patients with suspected pulmonary embolism (PE). Patients were categorized by largest occluded artery and aggregated into: ‘Require anti-coagulation’ (main, lobar, and segmental PE), ‘Does not require anti-coagulation’ (sub-segmental and No PE), ‘High risk of deterioration’ (main and lobar PE), and ‘Not high risk of deterioration’ (segmental, sub-segmental, and No PE) groups. Wilcoxon rank-sum test was used for 2 sample comparisons of median D-dimer concentrations. Receiver operating characteristic (ROC) curve analysis was utilized to determine a D-dimer cut-off that could differentiate ‘Require anti-coagulation’ from ‘Does not require anti-coagulation’ and ‘High risk of deterioration’ from ‘Low risk of deterioration’ groups. RESULTS: The ‘Require anti-coagulation’ group had a maximum area under the curve (AUC) of 0.92 at an age-adjusted D-dimer cut-off of 1540 with a specificity of 86% (95% CI, 81–91%), and sensitivity of 84% (79–90%). The ‘High risk of deterioration’ group had a maximum AUC of 0.93 at an age-adjusted D-dimer cut-off of 2500 with a specificity of 90% (85–93%) and sensitivity of 83% (77–90%). CONCLUSIONS: An age-adjusted D-dimer cut-off of 1540 ng/mL differentiates suspected PE patients requiring anti-coagulation from those not requiring anti-coagulation. A cut-off of 2500 differentiates those with high risk of clinical deterioration from those not at high risk of deterioration. When correlated with clinical outcomes, these cut-offs can provide an objective method for clinical decision making when imaging is unavailable. Pulmonary embolism (PE), a manifestation of venous thromboembolism (VTE) disease, is a potentially fatal condition often seen in the emergency department (ED) [1, 2] . Emboli most commonly arise from a thrombus in the deep veins of the legs or pelvis and travel to the pulmonary arteries, leading to occlusion of blood flow [1] . It is estimated that 1 in every 400 to 1500 adults in the ED will be diagnosed with a PE [2] . All-cause 30-day mortality after diagnosis of PE is 8%, making it the second leading cause of unexpected death in outpatients [2] . In patients with acute PE, current treatment guidelines recommend anticoagulation as first line therapy and inferior vena cava (IVC) filter or direct thrombolysis in a small set of unstable or very high risk patients [3, 4] . Presentation of PE varies from asymptomatic to hemodynamic collapse and shock, making it a diagnostic challenge. To aid in diagnosis, a D-dimer assay can be performed to rule out PE in patients with low pre-test probability [3] . D-dimer is a noninvasive, low-cost clinical assay that measures cross-linked fibrin degradation products. If a patient has a positive D-dimer test (usually >500 ng/mL) or has an intermediate or high pre-test probability based on clinical presentation, the patient should receive advanced imaging, such as computed tomography pulmonary angiogram (CTPA) or ventilation/perfusion scan (V/Q) [5] . The 500ng/mL D-dimer cut-off has shown to have a better predictive value when replaced with the age-adjusted cut-off using the formula: age (in years) x 10 for patients 50 years or older [6] . Mortality and disease recurrence rate is lower in patients with isolated subsegmental PE and higher in patients with more proximally located PE (main and lobar pulmonary arteries). This has led to discussion on which patients would benefit from anticoagulation [7] [8] [9] . Recent guidelines by the American College of Emergency Physicians (ACEP) and American College of Chest Physicians (ACCP) suggest to consider not anticoagulating patients with isolated sub-segmental PE and no proximal deep vein thrombosis (DVT) [3, 4] . Advanced imaging may not always be readily available, and CTPA is contraindicated in certain situations. This includes patients with contrast allergies, severe renal disease, recent contrast load, and those in whom there is a concern of radiation, such as children and pregnant women. V/Q scans are utilized if patients cannot undergo a CTPA but are cumbersome, require skilled technicians, and use technetium radioisotopes. In the absence of confirmatory imaging, ED providers must balance the risks and benefits of starting empiric treatment. Unnecessary anti-coagulation presents a danger of bleeding [10-12]. On the other hand, not treating a PE could lead to further embolization with resultant hemodynamic collapse and death, especially in patients with larger, more proximal emboli [9, [13] [14] [15] [16] . The ability to predict which patients suspected of PE require anti-coagulation when imaging is not available could aid in clinical decision making, decrease time to treatment, and prevent unnecessary bleeding risk. A D-dimer cut-off value would provide an objective tool to be used along with clinical gestalt while waiting for confirmatory imaging or in instances where imaging is not possible. The goal of this study was to establish a relationship between D-dimer concentration and PE location, and then to utilize this relationship to assess sensitivity and specificity of different D-dimer cut-points that stratify patients as needing or not needing empiric anti-coagulation. J o u r n a l P r e -p r o o f Our study was performed in a hospital system with 12 EDs across 2 states with a total average annual census of 500,000 adult and pediatric patients. Inclusion and exclusion criteria are outlined in Figure 1 . Key exclusion criteria included not having a D-dimer and CTPA within 24 hours of presentation to the ED and presence of factors that affect baseline D-dimer levels (active cancer, active use of anti-coagulation, chronic PE). There were 183 PE cases that met our study inclusion criteria. These patients were matched to negative controls from the same study period based on age (± 2 years), sex, exogenous estrogen use, and recent prolonged immobilization (defined as either hospitalization or surgery requiring overnight stay <30 days from ED visit or extended travel noted in chart by ED provider). Negative controls consisted of patients with J o u r n a l P r e -p r o o f Journal Pre-proof suspected PE that met our study inclusion criteria, including receiving a CTPA and Ddimer within 24-hours of entering the ED, but did not have a PE based on imaging results. Clinical variables, D-dimer concentration, and PE location were obtained from patient charts by trained abstractors. Patients were categorized by largest artery occluded as noted by radiology attending and further grouped based on a) requirement of anti-coagulation according to ACEP/ACCP guidelines and b) risk of clinical deterioration into the following: "Requires anti-coagulation" (main, lobar and segmental PE), "Does not require anti-coagulation" (sub-segmental and No PE), "High risk of deterioration" (main and lobar PE), and "Not high risk of deterioration" (segmental, sub-segmental, and No PE) groups. All "Subsegmental PE" patients had no evidence of proximal DVT as confirmed by venous duplex imaging. Age is presented as mean (standard deviation), D-dimer as median (interquartile range), and all categorical variables as count (percentage). Student"s t-test were used to assess group differences with respect to mean age. Chi-square tests were used to assess group differences with respect to categorical variables including sex, race, exogenous estrogen use, and recent immobilization. Wilcoxon rank-sum tests were used to assess for differences amongst the patient groups with respect to median adjusted D-dimer concentration. Additionally, the mean age adjusted D-dimer concentration was calculated for each of the four patient groups J o u r n a l P r e -p r o o f Journal Pre-proof and a Welch"s test was used to determine if difference in means were statistically significant while accommodating the unequal group variances. Separate receiver operating characteristic curve (ROC) analyses were performed to differentiate between the "Requires anti-coagulation" versus "Does not require anticoagulation" groups and the "High risk of deterioration" versus "Not high risk of deterioration" groups. Risk factors for PE were not included in the prediction model as the aim of our study was to utilize D-dimer concentration alone to determine whether a patient requires anti-coagulation. The sensitivity and specificity with 95% confidence interval (CI) were reported for the optimal D-dimer cut-off value simultaneously maximizing sensitivity and specificity, plus 3 other potentially clinically relevant cut-off values of 750, 2000, and 3000 ng/mL. All tests were two-sided and a significance level of 0.05 was utilized. Statistical analysis was performed using SAS JMP Pro Version 13 (SAS Institute, Cary, NC). There were 366 patients included in our study ( Figure 1 ). Patient characteristics and age-adjusted D-dimer concentrations are presented in Table 1 for "Requires Anti-Coagulation" and "Does not require anti-coagulation" groups and in Table 2 for "High risk of deterioration" and "Not high risk of deterioration" groups. All D-dimer concentrations are reported in ng/mL. Age-adjusted D-dimer concentrations increase with more proximal PE location ( Figure 2 ). There was a significant difference in median adjusted D-dimer concentration amongst the "Requires Anti-Coagulation" 4925 (IQR = 2020 -9768) and "Does not Mean (SD) age-adjusted D-dimer concentration for "Requires Anti-Coagulation" was 7437 (7552) and "Does not require anti-coagulation" was 1185 (2223) giving a mean difference between the two groups of 6252 (p<0.0001). Mean (SD) D-dimer concentration for "High risk of deterioration" was 8957 (7976) and "Not high risk of deterioration" was 1471 (2409) giving a mean difference between the two groups of 7486 (p<0.0001). ROC analysis was performed to differentiate "Requires anti-coagulation" from "Does not require anti-coagulation" patient groups based on age-adjusted D-dimer. we only included data about PE and not DVT. Patients with DVT are inherently more stable than PE patients, so the urgency to diagnose and treat is not as great. They concluded that there is a relationship between VTE location and D-dimer concentration, but a D-dimer value alone cannot predict whether a patient has a distal VTE due to low sensitivity (40.7%) and NPV (52.1%). We believe that our sensitivity and NPV for D- Limitations of our study include the retrospective nature of the work, which depends on physician charting that may possibly be incomplete. We were restricted to our enterprise"s electronic health record (EHR), so if a patient was recently admitted to another hospital we would not be able to identify that in our study. We did not evaluate clinically unstable patients. Further study is required to validate whether our D-dimer cutoff can be applied to this population and to patients where CT scans are not feasible including pregnant women, obese patients who cannot fit in scanners, and those with renal disease. Our D-dimer concentration cut-offs are comparable to CTPA (86% and 98% respectively) [24] . In addition, these cut-offs from our study population are superior to the current alternative of having no objective information or relying on gestalt alone for clinical decision making. J o u r n a l P r e -p r o o f We did not correlate clinical outcomes with our proposed D-dimer cut-offs, which could be evaluated in additional studies to prove that these cut-offs should be included in clinical decision rules when evaluating PE in adult ED patients. Strengths of this study include a large sample size and mix of adult patients from several locations ranging from a quaternary academic site to community EDs, enhancing external validity. In contrast to other PE studies, we focused solely on ED patients. Including an inpatient population could alter results as these patients are at an increased risk of VTE due primarily to stasis. We also controlled for several key confounding variables by matching (including gender, age, use of exogenous estrogen, and recent prolonged immobilization) and age-adjusting D-dimer concentrations. This study establishes a relationship between age-adjusted D  ED providers are faced with risks and benefits when empirically administering anti-coagulation for suspected PE patients.  We show that D-dimer concentration can be used as a clinical decision making tool to minimize these risks.  A D-dimer cut-off of 1540 ng/mL can be used to minimize unnecessary anti-coagulation exposure in patients who do not need it.  A D-dimer cut-off of 2500 ng/mL can be used to minimize risk of withholding treatment for patients at risk of clinical deterioration.  Together these cut-offs provide an objective measure that can be combined with clinical gestalt to weight the risks and benefits of empiric anti-coagulation. Pulmonary embolism Emergency evaluation for pulmonary embolism, Part 1: clinical factors that Increase Risk Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected acute venous thromboembolic disease Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report Emergency evaluation for pulmonary embolism, part 2: diagnostic approach Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study Systematic review and meta-analysis of outcomes of patients with subsegmental pulmonary embolism with and without anticoagulation Treatment Symptomatic subsegmental pulmonary embolism: what is the next step Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism Life-threatening haemorrhage in patients without pulmonary embolism who received anticoagulants We are grateful to Heather Bittner, RN for help with data retrieval